Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
Oren PasvolskySarah PasyarRoland L BassettHina N KhanMark R TannerQaiser BashirSamer A SrourNeeraj SainiPaul LinJeremy L RamdialYago L NietoHans C LeeKrina K PatelPartow KebriaeiSheeba K ThomasDonna M WeberRobert Z OrlowskiElizabeth J ShpallRichard E ChamplinMuzaffar H QazilbashPublished in: Cancer (2023)
In patients achieving ≥VGPR to induction, pretransplant MRDpos status was associated with a lower CR rate after autoHCT and a shorter PFS.